Skip to main content
. 2022 Feb 8;2022:7360282. doi: 10.1155/2022/7360282

Table 2.

Glucose, cortisol, and growth hormone responses to the ITT.

Standard dose 0.15 U/kg Low dose 0.10 U/kg
Glucose (mmol/L) n = 113 n = 61
Nadir mean ± SD (range) 1.07 ± 0.36 (0.30–2.20) 1.16 ± 0.40 (0.40–2.10)
Growth hormone (µg/L) n = 112 n = 60
Adequate response (>3.0) n (%) 82 (73.2%) 45 (75.0%)
 Mean ± SD (range) 13.3 ± 8.8 (3.1–44.9) 16.5 ± 12.4 (3.1–55.6)
Time point when >3 n (% of 82) n (% of 45)
 0 min. 6 (7%) 5 (11%)
 30 min. 25 (30%) 14 (31%)
 45 min. 63 (77%) 33 (73%)
 60 min. 81 (99%) 43 (96%)
 90 min. 82 (100%) 45 (100%)
 120 min.
Inadequate response (≤3.0) n (%) 30 (26.8%) 15 (25.0%)
 Mean ± SD (range) 1.1 ± 0.8 (0.1–2.8) 1.3 ± 1.0 (0.03–2.9)

Cortisol (nmol/L) n = 106 n = 60
Adequate response (>450) n (%) 77 (72.6%) 32 (53.3%)
 Mean ± SD (range) 560 ± 66 (456–799) 519 ± 61∗∗ (452–731)
Time point when >450 n (% of 77) n (% of 32)
 0 min. 3 (4%) 1 (3%)
 30 min. 5 (6%) 2 (6%)
 45 min. 36 (47%) 7 (22%)
 60 min. 71 (92%) 26 (81%)
 90 min. 77 (100%) 32 (100%)
 120 min.
Borderline response (400–450) n (%) 10 (9.4%) 7 (11.7%)
 Mean ± SD (range) 417 ± 27 (403–439) 424 ± 15 (409–440)
Inadequate response (<400) n (%) 19 (17.9%) 21 (35.0%)
 Mean ± SD (range) 233 ± 133 (19–393) 284 ± 121 (7–397)

p < 0.05 vs. standard, ∗∗∗p=0.001 vs. standard.